FDA Inspection
LifeStream Blood BankLifeStream Blood Bank – FDA Inspection, Oct 21, 2011
Record Details
This FDA Inspection record concerns LifeStream Blood Bank, with an inspection on October 21, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- LifeStream Blood Bank
- Inspection Date
- October 21, 2011
- Product Type
- Biologics
View Company Profile
ID · a1fd71a7-37b5-4b1e-9e57-afc6301ab744
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 749669
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of LifeStream Blood Bank
6| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2026 | Not classified | Los Angeles District Office | |
| October 27, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 22, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 17, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for LifeStream Blood Bank
- FDA Inspection 1302642 - 2026-02-05
- FDA Inspection 1132972 - 2020-10-27
- FDA Inspection 1059898 - 2018-06-22
- FDA Inspection 974737 - 2016-06-22
- FDA Inspection 896597 - 2014-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.